Rituximab/Thalidomide Regimen

Preferred Label : Rituximab/Thalidomide Regimen;

NCIt synonyms : Thalidomide-Rituximab Regimen; Rituxan/Thalomid; Rituximab-Thalidomide; Thalidomide/Rituximab; Rituximab/Thalidomide; Thalomid/Rituxan; Thalidomide-Rituximab;

NCIt related terms : Thalidomide and Rituximab; Thalidomide and Rituximab-rite; Thalidomide and Rituximab-rixi; Thalidomide and Rituximab-rixa; Thalidomide and Rituximab-blit; Thalidomide and Rituximab-abbs; Thalidomide and Rituximab-arrx; Thalidomide and Rituximab-pvvr;

NCIt definition : A regimen consisting of rituximab and thalidomide that may be used to treat mantle cell lymphoma and Castleman disease.;

NCIt note : Source: NCCN Guidelines 2007;

Codes from synonyms : 38567; 128797; 128012; 128169; 128326; 127855; 128483; 128640;

Details

Origin ID

C63466;

UMLS CUI

C1883287;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Rituximab [NCIt concept]
- Thalidomide [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Recurrent Mantle Cell Lymphoma [NCIt concept]
- Refractory Mantle Cell Lymphoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients